Palvella Therapeutics to Host Third Quarter 2025 Financial Results and Corporate Update Conference Call on November 11, 2025

Rhea-AI Summary

Palvella Therapeutics (Nasdaq: PVLA) will report third quarter 2025 financial results before market open on Tuesday, November 11, 2025. Management will host a conference call for investors at 8:30 a.m. ET the same day to discuss results and provide a corporate update.

A live webcast with slides will be available via the company's Events & Presentations page and a phone registration link will supply dial-in details. A replay of the webcast will be posted approximately 2 hours after the call and will be archived for 90 days at www.palvellatx.com.

WAYNE, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases for which there are no FDA-approved therapies, today announced that it will report its third quarter 2025 financial results before market open on Tuesday, November 11, 2025. Palvella management will host a conference call for investors at 8:30 a.m. ET on that same day to discuss the results and provide a corporate update.

To access the live webcast of the call with slides, please click here or visit the "Events & Presentations" section of Palvella’s website. To access the call by phone, please use this registration link, and you will be provided with dial in details. A replay of the webcast will be available approximately 2 hours after the conclusion of the call and archived for 90 days under the "Events & Presentations" section of the Company's website at www.palvellatx.com.

About Palvella Therapeutics

Founded and led by rare disease drug development veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella’s lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently being evaluated in the Phase 3 SELVA clinical trial in microcystic lymphatic malformations, the Phase 2 TOIVA clinical trial in cutaneous venous malformations, and a planned Phase 2 clinical trial in clinically significant angiokeratomas. For more information, please visit www.palvellatx.com or follow Palvella on LinkedIn or X (formerly known as Twitter).

QTORIN™ rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency for any indication.

Contact Information

Investors
Wesley H. Kaupinen
Founder and CEO, Palvella Therapeutics
wes.kaupinen@palvellatx.com

Media
Marcy Nanus
Managing Partner, Trilon Advisors, LLC
mnanus@trilonadvisors.com

FAQ

When will Palvella (PVLA) announce its Q3 2025 results?

Palvella will report Q3 2025 results before market open on November 11, 2025.

What time is the Palvella (PVLA) Q3 2025 conference call?

The investor call is scheduled for 8:30 a.m. ET on November 11, 2025.

How can I listen to the Palvella (PVLA) Q3 2025 webcast and view slides?

Access the live webcast and slides via the company's Events & Presentations page on www.palvellatx.com.

Can I join the Palvella (PVLA) call by phone and how do I get dial-in details?

Use the company's phone registration link to receive dial-in details and access instructions.

When will the replay of the Palvella (PVLA) Q3 2025 call be available and for how long?

A replay will be available about 2 hours after the call and archived for 90 days on the Events & Presentations page.

Where can investors find the Palvella (PVLA) conference call slides after the event?

Slides will be posted with the webcast on the company's Events & Presentations page at www.palvellatx.com and archived for 90 days.